Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth J Perlman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|March 14, 2012
LeukodystrophiesSeth J Perlman, Soe Mar
Journal of Child Neurology|September 7, 2012
Childhood Graves disease masquerading as myasthenia gravisSeth J Perlman, Craig M Zaidman
American Journal of Medical Genetics. Part A|March 16, 2013
Haploinsufficiency of ZNF238 is associated with corpus callosum abnormalities in 1q44 deletionsSeth J Perlman, Shashikant Kulkarni, Linda Manwaring, et al.
Clinical Pediatrics|May 13, 2014
Response to Eculizumab in Escherichia coli O157: H7-induced hemolytic uremic syndrome with severe neurological manifestationsArun Saini, Amanda R Emke, Manuel C Silva, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|January 19, 2023
Inpatient rehabilitation admission for a patient with spinal muscular atrophy status post gene therapyJaclyn C Omura, Casey L Freeman, Seth J Perlman, et al.
Journal of Child Neurology|April 12, 2013
Evidence-based decision support for neurological diagnosis reduces errors and unnecessary workupMichael M Segal, Marc S Williams, Andrea L Gropman, et al.
Genetics in Medicine Open|November 1, 2024
Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testingJonathan Marquez, Jennifer N Cech, Cate R Paschal, et al.
American Journal of Human Genetics|July 3, 2021
Targeted long-read sequencing identifies missing disease-causing variationDanny E Miller, Arvis Sulovari, Tianyun Wang, et al.
Neurology|February 9, 2024
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled TrialUtkarsh J Dang, Jesse M Damsker, Michela Guglieri, et al.
JAMA Neurology|August 29, 2022
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical TrialMichela Guglieri, Paula R Clemens, Seth J Perlman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|March 14, 2012
LeukodystrophiesSeth J Perlman, Soe Mar
Journal of Child Neurology|September 7, 2012
Childhood Graves disease masquerading as myasthenia gravisSeth J Perlman, Craig M Zaidman
American Journal of Medical Genetics. Part A|March 16, 2013
Haploinsufficiency of ZNF238 is associated with corpus callosum abnormalities in 1q44 deletionsSeth J Perlman, Shashikant Kulkarni, Linda Manwaring, et al.
Clinical Pediatrics|May 13, 2014
Response to Eculizumab in Escherichia coli O157: H7-induced hemolytic uremic syndrome with severe neurological manifestationsArun Saini, Amanda R Emke, Manuel C Silva, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|January 19, 2023
Inpatient rehabilitation admission for a patient with spinal muscular atrophy status post gene therapyJaclyn C Omura, Casey L Freeman, Seth J Perlman, et al.
Journal of Child Neurology|April 12, 2013
Evidence-based decision support for neurological diagnosis reduces errors and unnecessary workupMichael M Segal, Marc S Williams, Andrea L Gropman, et al.
Genetics in Medicine Open|November 1, 2024
Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testingJonathan Marquez, Jennifer N Cech, Cate R Paschal, et al.
American Journal of Human Genetics|July 3, 2021
Targeted long-read sequencing identifies missing disease-causing variationDanny E Miller, Arvis Sulovari, Tianyun Wang, et al.
Neurology|February 9, 2024
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled TrialUtkarsh J Dang, Jesse M Damsker, Michela Guglieri, et al.
JAMA Neurology|August 29, 2022
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical TrialMichela Guglieri, Paula R Clemens, Seth J Perlman, et al.
Pageof 2